Clinical trial

Renin Angiotensin System Study (RASS/B-RASS)

NCT00143949

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1997-03-01

PhasePHASE2

Study timeline

Study start (unknown)1997-03-01Date precision: month

Registry last updated2008-11-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesverified · MONDO: type 1 diabetes mellitus

Interventions

enalaprilDRUG · verified · RxNorm: enalapril

losartanDRUG · verified · RxNorm: losartan

Sponsors & collaborators

Michael Mauer, MDlead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Merck Sharp & Dohme LLCcollaborator

Merck Frosst Canada Ltd.collaborator

Canadian Institutes of Health Research (CIHR)collaborator

Mapped research locations

MontrealQuebec, Canada2 TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00143949 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.